This site is intended only for healthcare professionals residing in Singapore
Driving innovation is in our blood, so the promise of potential breakthroughs can reach our patients. Supporting patients and those who treat them is our honor, our responsibility, and our passion.
With marketed and investigational therapies, Pfizer is working to overcome the challenges of hematologic cancers and deliver innovative treatments to patients. Pfizer Oncology is committed to partnering with patient, caregiver, and scientific communities to provide information and resources to help improve patient care.
Embark on a journey to learn more about the management of ALL through a wide range of resources including clinical data and downloadable treatment management materials.
Embark on a journey to learn more about the management of AML through a wide range of resources including clinical data and downloadable treatment management materials.
Register here to find out more about upcoming events and to get up-to-date answers on Pfizer’s hematological portfolio of innovative agents.
To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.
The information provided in this site is intended only for Healthcare Professionals in Singapore. The products discussed herein may have different product labelling in different countries. Pfizer Pte Ltd, Singapore is a subsidiary of Pfizer Inc, a pharmaceutical company committed to helping people improve their health by discovering and developing medicines.
Copyright © 2023 Pfizer Limited. All rights reserved.